Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer


Creative Commons License

Ercelep O., Tataroglu D., Ozcelik M., Surmeli H., Degirmenci M., Inanc M., ...More

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.17, no.2, pp.123-127, 2020 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.4274/tjod.galenos.2020.90699
  • Journal Name: TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
  • Journal Indexes: Emerging Sources Citation Index, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.123-127

Abstract

Objective: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer.